Pfizer Statistics

Total Valuation

Pfizer has a market cap or net worth of CAD 183.82 billion. The enterprise value is 247.36 billion.

Market Cap	183.82B
Enterprise Value	247.36B

Important Dates

The last earnings date was Tuesday, April 29, 2025.

Earnings Date	Apr 29, 2025
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	n/a
Shares Outstanding	n/a
Shares Change (YoY)	+0.97%
Shares Change (QoQ)	+0.12%
Owned by Insiders (%)	n/a
Owned by Institutions (%)	n/a
Float	5.68B

Valuation Ratios

The trailing PE ratio is 16.32 and the forward PE ratio is 8.05.

PE Ratio	16.32
Forward PE	8.05
PS Ratio	2.06
PB Ratio	1.42
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 7.16, with an EV/FCF ratio of 15.43.

EV / Earnings	21.96
EV / Sales	2.83
EV / EBITDA	7.16
EV / EBIT	10.62
EV / FCF	15.43

Financial Position

The company has a current ratio of 1.26, with a Debt / Equity ratio of 0.69.

Current Ratio	1.26
Quick Ratio	0.88
Debt / Equity	0.69
Debt / EBITDA	2.55
Debt / FCF	5.56
Interest Coverage	5.57

Financial Efficiency

Return on equity (ROE) is 8.62% and return on invested capital (ROIC) is 6.52%.

Return on Equity (ROE)	8.62%
Return on Assets (ROA)	4.79%
Return on Invested Capital (ROIC)	6.52%
Return on Capital Employed (ROCE)	9.58%
Revenue Per Employee	1.10M
Profits Per Employee	139,050
Employee Count	81,000
Asset Turnover	0.29
Inventory Turnover	1.47

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -19.94% in the last 52 weeks. The beta is 0.50, so Pfizer's price volatility has been lower than the market average.

Beta (5Y)	0.50
52-Week Price Change	-19.94%
50-Day Moving Average	11.12
200-Day Moving Average	12.38
Relative Strength Index (RSI)	44.69
Average Volume (20 Days)	128,329

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	2.15

Income Statement

In the last 12 months, Pfizer had revenue of CAD 89.25 billion and earned 11.26 billion in profits. Earnings per share was 1.98.

Revenue	89.25B
Gross Profit	66.42B
Operating Income	23.50B
Pretax Income	10.55B
Net Income	11.26B
EBITDA	33.32B
EBIT	23.50B
Earnings Per Share (EPS)	1.98

Full Income Statement

Balance Sheet

The company has 24.75 billion in cash and 89.15 billion in debt, giving a net cash position of -64.41 billion.

Cash & Cash Equivalents	24.75B
Total Debt	89.15B
Net Cash	-64.41B
Net Cash Per Share	n/a
Equity (Book Value)	129.50B
Book Value Per Share	22.70
Working Capital	13.44B

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 19.99 billion and capital expenditures -3.96 billion, giving a free cash flow of 16.03 billion.

Operating Cash Flow	19.99B
Capital Expenditures	-3.96B
Free Cash Flow	16.03B
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross margin is 74.42%, with operating and profit margins of 26.33% and 12.62%.

Gross Margin	74.42%
Operating Margin	26.33%
Pretax Margin	11.82%
Profit Margin	12.62%
EBITDA Margin	37.34%
EBIT Margin	26.33%
FCF Margin	17.96%

Dividends & Yields

Pfizer does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	121.49%
Buyback Yield	-0.97%
Shareholder Yield	-0.97%
Earnings Yield	6.13%
FCF Yield	8.72%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Pfizer has an Altman Z-Score of 2.22. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	2.22
Piotroski F-Score	n/a